Search

Your search keyword '"Korobelnik, Jean-Francois"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Korobelnik, Jean-Francois" Remove constraint Author: "Korobelnik, Jean-Francois" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
22 results on '"Korobelnik, Jean-Francois"'

Search Results

1. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

4. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

5. Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

6. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

9. Physical Activity, Incidence, and Progression of Age-Related Macular Degeneration: A Multicohort Study

10. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

11. Faricimab Treat-and-Extend for Diabetic Macular Edema

12. Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration

15. Recommendations for OCT Angiography Reporting in Retinal Vascular Disease

16. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.

18. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

19. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

20. Recommendations for OCTA reporting in retinal vascular disease: A Delphi approach by International Experts

22. Quantitative Analysis of Radial Peripapillary Capillary Network in Patients With Papilledema Compared with Healthy Subjects Using Optical Coherence Tomography Angiography.

Catalog

Books, media, physical & digital resources